• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Reduced Accuracy of Non-invasive Tests for Significant Fibrosis in Chronic Hepatitis B Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.

作者信息

Rui Fajuan, Ni Wenjing, Yeo Yee Hui, Tan Youwen, Xu Liang, Shi Junping, Li Jie

机构信息

Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

出版信息

J Clin Transl Hepatol. 2024 Sep 28;12(9):827-829. doi: 10.14218/JCTH.2024.00048. Epub 2024 Jul 9.

DOI:10.14218/JCTH.2024.00048
PMID:39280067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393840/
Abstract
摘要

相似文献

1
The Reduced Accuracy of Non-invasive Tests for Significant Fibrosis in Chronic Hepatitis B Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病的慢性乙型肝炎患者中，显著肝纤维化无创检测的准确性降低
J Clin Transl Hepatol. 2024 Sep 28;12(9):827-829. doi: 10.14218/JCTH.2024.00048. Epub 2024 Jul 9.
2
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.用于检测代谢功能障碍相关脂肪性肝病患者显著纤维化的非侵入性检测组合并不优于单独使用磁共振弹性成像。
Eur Radiol. 2024 Jun;34(6):3882-3888. doi: 10.1007/s00330-023-10441-5. Epub 2023 Nov 21.
3
Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.非侵入性检测在患有脂肪性肝病不同命名的慢性乙型肝炎患者的肝纤维化进展中具有较高的准确性。
J Med Virol. 2024 Apr;96(4):e29613. doi: 10.1002/jmv.29613.
4
Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.合并代谢相关脂肪性肝病对慢性乙型肝炎患者系列无创性纤维化标志物的影响。
Dig Dis Sci. 2024 Apr;69(4):1496-1506. doi: 10.1007/s10620-024-08354-4. Epub 2024 Feb 20.
5
A Clinical Review of Noninvasive Tests for Hepatic Fibrosis.肝纤维化无创检测的临床综述
Gastroenterol Hepatol (N Y). 2024 Aug;20(6):322-329.
6
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease.FibroMeter评分是慢性病毒性肝炎或代谢功能障碍相关脂肪性肝病患者晚期和显著肝纤维化的预测性非侵入性标志物。
Ann Gastroenterol. 2023 Nov-Dec;36(6):661-669. doi: 10.20524/aog.2023.0841. Epub 2023 Nov 3.
7
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.代谢相关脂肪性肝病在三级中心炎症性肠病中的患病率及相关危险因素。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231321. doi: 10.1590/1806-9282.20231321. eCollection 2024.
8
Longitudinal Follow-Up of Fibrosis-4 in Patients at Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease Receiving Low-Dose Methotrexate Treatment.接受低剂量甲氨蝶呤治疗的代谢功能障碍相关脂肪性肝病风险患者的纤维化 4 号的纵向随访。
Clin Gastroenterol Hepatol. 2024 Nov;22(11):2337-2339. doi: 10.1016/j.cgh.2024.03.035. Epub 2024 Apr 24.
9
Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver disease.探索自身抗体作为脂肪性肝病相关代谢功能障碍中严重纤维化或肝硬化预测指标的作用。
Can Liver J. 2024 May 8;7(2):291-298. doi: 10.3138/canlivj-2023-0026. eCollection 2024 May.
10
Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.代谢功能障碍相关脂肪性肝病患者中预后血清生物标志物预测肝纤维化严重程度的准确性：一项纳入40000多名参与者的荟萃分析
Front Nutr. 2024 Feb 14;11:1284509. doi: 10.3389/fnut.2024.1284509. eCollection 2024.

本文引用的文献

1
Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.代谢功能障碍相关脂肪性肝病患者中预后血清生物标志物预测肝纤维化严重程度的准确性：一项纳入40000多名参与者的荟萃分析
Front Nutr. 2024 Feb 14;11:1284509. doi: 10.3389/fnut.2024.1284509. eCollection 2024.
2
Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.亚洲慢性乙型肝炎患者肝脂肪变的临床影响：系统评价和荟萃分析。
J Viral Hepat. 2023 Oct;30(10):793-802. doi: 10.1111/jvh.13872. Epub 2023 Aug 2.
3
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
非酒精性脂肪性肝病中纤维化和非酒精性脂肪性肝炎的分期生物标志物（LITMUS 项目）：一项比较诊断准确性研究。
Lancet Gastroenterol Hepatol. 2023 Aug;8(8):714-725. doi: 10.1016/S2468-1253(23)00017-1. Epub 2023 Mar 21.
4
Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease.乙型肝炎病毒感染合并非酒精性脂肪性肝病的临床影响和机制。
Chin Med J (Engl). 2022 Jul 20;135(14):1653-1663. doi: 10.1097/CM9.0000000000002310.
5
Impact of non-invasive biomarkers on hepatology practice: Past, present and future.非侵入性生物标志物对肝脏病学实践的影响：过去、现在和未来。
J Hepatol. 2022 Jun;76(6):1362-1378. doi: 10.1016/j.jhep.2022.03.026.
6
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.2 型糖尿病对肝纤维化无创性检测准确性的影响及其临床意义。
Clin Gastroenterol Hepatol. 2023 May;21(5):1243-1251.e12. doi: 10.1016/j.cgh.2022.02.059. Epub 2022 Mar 11.
7
Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B.系统评价与荟萃分析：慢性乙型肝炎患者肝脂肪变、肝纤维化及其相关因素的流行情况。
Aliment Pharmacol Ther. 2021 Nov;54(9):1100-1109. doi: 10.1111/apt.16595. Epub 2021 Sep 1.
8
Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.纤维化 4 指数与非酒精性脂肪性肝病纤维化评分在非酒精性脂肪性肝病患者中识别肝纤维化程度的比较：一项荟萃分析。
Am J Gastroenterol. 2021 Sep 1;116(9):1833-1841. doi: 10.14309/ajg.0000000000001337.
9
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.非酒精性脂肪性肝病患者肝纤维化无创性检查诊断准确性的个体患者数据分析荟萃研究。
Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243. Epub 2021 May 17.
10
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.